Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Lynrock Lake LP | OSS One Stop Systems, Inc. | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| Point72 Hong Kong Ltd | HUYA HUYA Inc. | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | LL LL Flooring Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | ZIP Ziprecruiter, Inc. | 13G/A | 10.08% | Dec 31, 2023 | 2y |
| Divisadero Street Capital Management, LP | GRPN Groupon, Inc. | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| Energy Income Partners, LLC | WLKP Westlake Chemical Partners LP | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| Granahan Investment Management, LLC | CSTL Castle Biosciences Inc | 13G | 8.05% | Dec 31, 2023 | 2y |
| Anders Hove | XFOR X4 Pharmaceuticals, Inc | 13G | 9.99% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | ALIT Alight, Inc. / Delaware | 13G/A | 6.32% | Dec 31, 2023 | 2y |
| SPURWINK MANAGEMENT LLC | GPGI GPGI, Inc. | 13G/A | 6.8% | Dec 31, 2023 | 2y |
| Yuansheng International Limited | SFWL SHENGFENG DEVELOPMENT Ltd | 13G | 9.3% | Dec 31, 2023 | 2y |
| CONTINENTAL GENERAL INSURANCE CO | SRAX SRAX, Inc. Class A Common Stock | 13G/A | 7.7% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | PGSS Pegasus Digital Mobility Acquisition Corp. | 13G/A | 14.82% | Dec 31, 2023 | 2y |
| P SCHOENFELD ASSET MANAGEMENT LP | LUNR Intuitive Machines, Inc. | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| Ionic Ventures, LLC | INBS Intelligent Bio Solutions Inc. | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| EcoR1 Capital, LLC | NGM NGM Biopharmaceuticals, Inc. Common Stock | 13G/A | 2.9% | Dec 31, 2023 | 2y |
| Casdin Capital, LLC | MXCT Maxcyte, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | DY Dycom Industries Inc | 13G/A | 5.9% | Dec 31, 2023 | 2y |
| Long Focus Capital Management, LLC | CLLS Cellectis S.A. | 13G/A | 6.3% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | SBH Sally Beauty Holdings, Inc. | 13G/A | 0.1% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | JBIO Jade Biosciences, Inc. | 13G/A | 6.1% | Dec 31, 2023 | 2y |
| Ancient Art, L.P. | DESP Despegar.com, Corp. | 13G/A | 5.4% | Dec 31, 2023 | 2y |
| Atreides Management, LP | RH Rh | 13G | 6.85% | Dec 31, 2023 | 2y |
| Pfizer Inc | AKRO Akero Therapeutics, Inc. Common Stock | 13G/A | 4.53% | Dec 31, 2023 | 2y |
| OnyxPoint Global Management LP | ESTE Earthstone Energy Inc. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | RDCM Radcom Ltd | 13G | 5.3% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | GHRS GH Research PLC | 13G | 6.4% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | NRIX Nurix Therapeutics, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares | 13G/A | 7.27% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | WELL Welltower Inc. | 13G/A | 7.49% | Dec 31, 2023 | 2y |
| Nextech V Oncology S.C.S., SICAV-SIF | KNTE Kinnate Biopharma Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | QURE uniQure N.V. | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | CURR Currenc Group Inc. | 13G/A | 6.13% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | PMVP PMV Pharmaceuticals, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | EMAT Evolution Metals & Technologies Corp. | 13G | 5.49% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | MANH Manhattan Associates Inc | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | AMLX Amylyx Pharmaceuticals, Inc. | 13G/A | 4.7% | Dec 31, 2023 | 2y |
| GENERATION INVESTMENT MANAGEMENT LLP | SOPH SOPHiA GENETICS SA | 13G/A | 10.42% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | VEEV Veeva Systems Inc | 13G/A | 4.2% | Dec 31, 2023 | 2y |
| Jacques Frederic Kerrest | OKTA Okta, Inc. | 13G/A | 1.9% | Dec 31, 2023 | 2y |
| SPRUCE HOUSE INVESTMENT MANAGEMENT LLC | W Wayfair Inc. | 13G/A | 4.5% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | FDMT 4D Molecular Therapeutics, Inc. | 13G/A | 8.9% | Dec 31, 2023 | 2y |
| M3 Funds, LLC | RBKB Rhinebeck Bancorp, Inc. | 13G/A | 9.51% | Dec 31, 2023 | 2y |
| Irenic Capital Management LP | TBPH Theravance Biopharma, Inc. | 13G | 5.5% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | SBLK Star Bulk Carriers Corp. | 13G/A | 6.4% | Dec 31, 2023 | 2y |
| Prime Link Capital International Limited | SFWL SHENGFENG DEVELOPMENT Ltd | 13G | 7.6% | Dec 31, 2023 | 2y |
| Kevin P. Reilly, Jr. | LAMR Lamar Advertising Co | 13G/A | 11.6% | Dec 31, 2023 | 2y |
| ARISTEIA CAPITAL, L.L.C. | CUK CARNIVAL PLC | 13G/A | 8.17% | Dec 31, 2023 | 2y |
| Yang Lu | ANL Adlai Nortye Group Ltd. | 13G | 17.5% | Dec 31, 2023 | 2y |
| Amar K. Goel | PUBM PubMatic, Inc. | 13G/A | 10.4% | Dec 31, 2023 | 2y |